Danaher Co. (NYSE:DHR) Shares Acquired by WealthPLAN Partners LLC
WealthPLAN Partners LLC lifted its holdings in shares of Danaher Co. (NYSE:DHR) by 1.1% during the 4th quarter, Holdings Channel.com reports. The fund owned 30,340 shares of the conglomerate’s stock after buying an additional 327 shares during the period. WealthPLAN Partners LLC’s holdings in Danaher were worth $7,146,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also modified their holdings of the company. Hudock Inc. raised its position in shares of Danaher by 526.3% during the 4th quarter. Hudock Inc. now owns 119 shares of the conglomerate’s stock worth $26,000 after acquiring an additional 100 shares in the last quarter. Financial Avengers Inc. acquired a new stake in shares of Danaher during the 4th quarter worth about $40,000. Atlas Private Wealth Management acquired a new stake in shares of Danaher during the 3rd quarter worth about $41,000. Oakworth Capital Inc. raised its position in shares of Danaher by 48.9% during the 3rd quarter. Oakworth Capital Inc. now owns 198 shares of the conglomerate’s stock worth $43,000 after acquiring an additional 65 shares in the last quarter. Finally, University of Texas Texas AM Investment Managment Co. acquired a new position in Danaher during the third quarter worth approximately $53,000. 78.00% of the stock is currently owned by institutional investors and hedge funds.
In related news, SVP Angela S. Lalor sold 6,437 shares of Danaher stock in a transaction that occurred on Friday, February 12th. The stock was sold at an average price of $244.70, for a total value of $1,575,133.90. Following the sale, the senior vice president now directly owns 25,148 shares in the company, valued at $6,153,715.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 11.70% of the company’s stock.
Danaher (NYSE:DHR) last posted its quarterly earnings data on Thursday, January 28th. The conglomerate reported $2.08 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.84 by $0.24. Danaher had a net margin of 18.05% and a return on equity of 12.94%. The firm had revenue of $6.76 billion for the quarter, compared to the consensus estimate of $6.62 billion. During the same quarter in the prior year, the company posted $1.28 earnings per share. The company’s revenue for the quarter was up 38.9% compared to the same quarter last year. Research analysts expect that Danaher Co. will post 6.05 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, January 29th. Stockholders of record on Monday, December 28th were paid a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.32%. The ex-dividend date of this dividend was Thursday, December 24th. Danaher’s payout ratio is presently 16.29%.
Several research firms have commented on DHR. Credit Suisse Group lifted their price target on Danaher from $260.00 to $264.00 and gave the stock an “outperform” rating in a research report on Thursday, January 14th. The Goldman Sachs Group began coverage on Danaher in a research report on Wednesday, December 2nd. They set a “buy” rating and a $250.00 price target on the stock. Royal Bank of Canada lowered Danaher from an “outperform” rating to a “sector perform” rating and cut their price target for the stock from $273.00 to $234.00 in a research report on Wednesday, November 25th. KeyCorp initiated coverage on Danaher in a report on Monday, November 9th. They issued an “overweight” rating and a $280.00 target price on the stock. Finally, Needham & Company LLC boosted their price target on Danaher from $209.00 to $272.00 in a report on Tuesday, October 27th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $233.00.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
See Also: Green Investing
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.